We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

127 hedge funds and large institutions have $784M invested in Foundation Medicine, Inc. in 2017 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 30 increasing their positions, 33 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 11

163% more call options, than puts

Call options by funds: $41.3M | Put options by funds: $15.7M

65% more capital invested

Capital invested by funds: $476M → $784M (+$307M)

31% more funds holding

Funds holding: 97127 (+30)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

9% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 33

Holders
127
Holders Change
+30
Holders Change %
+30.93%
% of All Funds
2.87%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
42
Increased
30
Reduced
33
Closed
11
Calls
$41.3M
Puts
$15.7M
Net Calls
+$25.6M
Net Calls Change
+$9.98M

FMI Hedge Fund Activity: Q4 2017 in Review

127 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q4 2017, worth a combined $784M — up 65% from $476M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new FMI positions and 11 closed out — a net gain of 31 holders — while 30 added to existing stakes and 33 trimmed.

The largest buyer was Hitchwood Capital Management, opening a new position worth an estimated $18.7M. The largest seller was AllianceBernstein, cutting an estimated $19.1M.

  • 127 institutional investors held Foundation Medicine, Inc. (FMI) as of Q4 2017, up from 97 in Q3 2017.
  • Funds reported $784M of Foundation Medicine, Inc. stock for Q4 2017, up 65% quarter-over-quarter.
  • 42 funds opened new Foundation Medicine, Inc. positions in Q4 2017 and 11 closed out, a net change of +31 holders.
  • The largest Foundation Medicine, Inc. buyer in Q4 2017 was Hitchwood Capital Management, an estimated $18.7M added.
  • The largest Foundation Medicine, Inc. seller in Q4 2017 was AllianceBernstein, an estimated $19.1M sold.

Based on aggregated 13F filings for Q4 2017.